StockMarketWire.com - Verona Pharma said it received notification that on 20 January 2016 David Ebsworth, a Director of the Company, purchased 400,000 ordinary shares of 0.1p each at a price of 2.5p per share.

Following this latest transaction Ebsworth has a total interest of 4,599,774 Ordinary Shares, representing 0.46% of the total voting rights.



At 12:32pm: [LON:VRP] Verona Pharma PLC share price was +0.08p at 2.45p



Story provided by StockMarketWire.com